Channel
@virologynews
On this record: Topic · Growth · Engagement · Reactions · Posts · Citations · Cite this entry
483subscribers
+1 since we began measuring on 6 August 2026
Risers and fallers across the register · movement among entries of Under 1,000.
| Telegram ID | -1001245609945 |
|---|---|
| Type | Channel |
| Username | @virologynews |
| Created | Between 1 March 2018 and 31 August 2021 — estimated from Telegram’s id allocation, not measured. How this range is calculated. |
| First recorded | 6 August 2026 |
| Last confirmed live | 12 September 2026 |
| Measurements held | 5 |
| Confirmed unchanged | 2 times, most recently 12 September 2026 |
| On Telegram | t.me/virologynews |
Science — a classification, not a measurement. An on-box language model (Qwen3.6-35B-A3B-FP8, prompt version 1) read this channel’s own recent posts on 21 September 2026 and assigned it the closest of 31 fixed categories, at 84% confidence. This is a model’s judgement about what the channel is likely to be about, not a fact this register measured the way a subscriber count or a view count is measured — it can be revised on a later pass, and it carries no weight anywhere else on this page. How this classification works, and why it has no browse page of its own yet.
| Measured (UTC) | Subscribers | Change |
|---|---|---|
| 3 Sept 2026, 19:00 | 483 | +2 |
| 27 Aug 2026, 13:12 | 481 | +1 |
| 14 Aug 2026, 21:23 | 480 | -2 |
| 6 Aug 2026, 18:48 | 482 | no change |
| 6 Aug 2026, 15:04 | 482 | first reading |
13 posts held, back to 3 June 2026 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 page of Telegram’s post history, 20 posts per page.
Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 13 posts for this entry, the most recent from 5 August 2026. An engagement rate over an empty window would be a number about nothing.
22 reactions across 10 posts, in 5 distinct kinds. The most used accounts for 40.9% of them.
| Reaction | Count | Share | Share, drawn |
|---|---|---|---|
| 👌 | 9 | 40.9% | |
| ❤ | 8 | 36.4% | |
| 👍 | 3 | 13.6% | |
| ⚡ | 1 | 4.55% | |
| 👏 | 1 | 4.55% |
No sentiment is inferred, and none should be read in. This table is ordered by count and by nothing else. Emoji do not carry stable meaning across languages or communities — 🙏 is thanks in one channel and mourning in another — so we publish which ones were pressed and how often, and pass no judgement on what an audience meant by them.
Precision. Telegram publishes reaction counts per emoji and short-forms each one — 4.34K, 1.2M — so any single kind at or above 1,000 reaches us at three significant figures, and only counts below 1,000 are exact. The shares above are ratios of those figures and carry the same error. This is also why the total here can differ slightly from a reaction total printed elsewhere on the page: both are sums of the same rounded parts, taken over samples with different edges.
Coverage. Reactions were read on 10 of the 13 sampled posts in this sample. Summed by Telegram’s own count on each post — not by adding up the per-emoji breakdown above — those same posts carry 22 reactions in total: the kind of figure the paragraph above means by “a reaction total printed elsewhere on the page”.
Measured over the 13 most recent posts we hold, published 3 June 2026 to 5 August 2026, using the newest reading held for each. Telegram Stars are excluded: they are a payment, not a reaction, and they have their own section.
Cancer-fighting chewing gum cut HPV levels by up to 93% ✅ Researchers developed a bioengineered chewing gum that sharply reduced three microbes linked to head and neck cancers. These include human papillomavirus, or HPV, along with two bacterial species, Porphyromonas gingivalis (Pg) and Fusobacterium nucleatum (Fn). 🔺Head and neck squamous cell carcinoma (HNSCC) is a common form of cancer that begins in the tissue…
❤2
🦠 Hepatitis and FIVE VIRAL agents #Infographic #Hepatitis @virologynews 🔬🔬🔬🔬🔬
👍1👏1
Global hepatitis report 2026 Viral hepatitis is one of the world’s most important public health challenges. Hepatitis B virus (HBV) and hepatitis C virus (HCV) cause chronic infection, leading to cirrhosis, liver cancer and over one million premature deaths every year. Although both infections are preventable and treatable, HBV and HCV together account for more than 95% of mortality from viral hepatitis. @virology…
❤2👌1
✅ از مهندسی ویروس تا درمان تومور 🔸تشریح موفقیت در درمان تومور های بدخیم مغزی گلیوبلاستوما با تلقیح انکولایتیک ویروس سرخک مهندسی شده 🗓️ تاریخ ۱۰ مرداد ساعت ۹ الی ۱۲ 🔸امتیاز بازآموزی از سامانه آموزش مداوم برای همکاران ویروس شناس 📎 لینک ثبت نام http://cmelearn.ir/course/257169 @virologynews 🔬🔬🔬🔬🔬
🗓️ روز جهانی هپاتیت | ۲۸ جولای ۲۰۲۶ هپاتیت ویروسی، التهاب کبد است که میتواند به بیماری کبدی و سرطان منجر شود. هر سال میلیونها نفر بهدلیل انگ اجتماعی، آگاهی محدود یا نبود دسترسی به خدمات، بدون تشخیص یا درمان باقی میمانند — درحالیکه ابزارهای مؤثر پیشگیری و درمان هماکنون در دسترساند. شعار امسال: «هپاتیت: بیایید موانع را بشکنیم» بیایید هپاتیت را بهتر بشناسیم. #روز_جهانی_هپاتیت . 🗓️ World Hepatitis Day | 28 July 20…
👍1
نتایج امیدوارکننده درمان سرطان مغز با ویروس سرخک در ایران ◀️فانا گزارش میدهد: 🔹یک درمان توسعه یافته توسط محققان ایرانی برای تومورهای مغزی بدخیم در مراحل اولیه مطالعات بالینی، نتایج امیدوارکنندهای از خود نشان داده است 🔹این درمان در فاز اول مطالعات بالینی، روی ۹ بیمار مبتلا به گلیوبلاستوما مولتی فرم (GBM) به عنوان شایعترین نوع تومور بدخیم مغز در بزرگسالان، آزمایش شد 🔹این درمان، یک ویروس انکولیتیک است که بر پایه …
❤2👌2⚡1
Cruise ship-linked Hantavirus outbreak ends ✌🏻The World Health Organization has declared that the cruise ship (MV Hondius) linked Hantavirus outbreak has ended. Contact tracing with the absence of further secondary cases, indicates effective interruption of transmission and confirmation of containment of the outbreak. The outbreak no longer poses a public health risk and no further transmission associated with this …
👍1
نهمین گزارش هفتگی تهدیدات بهداشتی جهان با موضوع وضعیت جهانی بیماری سرخک در سال 2026 تهیه شده توسط مرکز تحقیقات بیماری های نوپدید و بازپدید انستیتو پاستور ایران با همکاری مرکز مدیریت بیماری های واگیر وزارت بهداشت، درمان و آموزش پزشکی منتشر گردید ♦️ مرکز تحقیقات بیماریهای نوپدید و بازپدید تلگرام https://t.me/EmergingInfDis ایتا https://eitaa.com/EmerginginfDis بله https://ble.ir/@EmergingInfDis
👌2
💻 AI-designed universal coronavirus vaccine passes first human trial! ▪️Developed by researchers at the University of Cambridge and the university spinout company DIOSynVax (DVX) Ltd, the experimental vaccine was found to be safe and caused no significant side effects in a study involving 39 healthy volunteers. ▪️It was the first time a vaccine whose active ingredient was created entirely through computer simulatio…
❤2
🔷 وبینار سازمان بهداشت جهانی درباره هانتاویروس 🔹سازمان بهداشت جهانی (WHO) چهارمین وبینار تخصصی خود را در زمینه پیشگیری و کنترل عفونت هانتاویروس برگزار میکند. 🔹سازمان بهداشت جهانی در قالب سری وبینارهای EPI-WIN، نشست تخصصی «هانتاویروس در کانون توجه IV» را با محوریت پیشگیری و کنترل عفونت: از ایزولاسیون تا ترخیص ایمن و قرنطینه برگزار خواهد کرد. 🔹این رویداد علمی روز سهشنبه، ۲۶ خرداد ۱۴۰۵ از ساعت ۱۶:۳۰ تا ۱۷:۳۰ به وق…
👌3
وبینار هانتاویروس دنیای قدیم و جدید، تشخیص و کنترل 🗓️ زمان: دوشنبه ۲۵ خرداد ۱۴۰۵ ساعت ۹-۱۲ ✨دارای امتیاز بازآموزی 🌐 لینک شرکت در وبینار: http://event.alocom.co/class/fums/ism @virologynews 🔬🔬🔬🔬🔬
EU secures emergency deliveries of potential treatment against hantavirus 🔸The first doses of an experimental antiviral for hantavirus treatment are being dispatched to France, Spain and the Netherlands, the European Commission said on Thursday. 🔸In the absence of a specific treatment for hantavirus, the European Medicines Agency identified favipiravir as the most plausible candidate for use under clinical trial …
👌1
Showing the 12 most recent of 13 posts we hold for @virologynews. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.
Republishes
Channels on the register whose posts this channel has forwarded.
Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.
Names
Channels on the register whose handles appear in this channel's posts.
A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.
A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 3 September 2026 — this entry's latest reading, not the date you are reading this.
“Virology News” (@virologynews), 483 subscribers as measured 3 September 2026. Telegram Register, tgregister.com/channel/virologynews.
Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.